CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...
Phase 3
Roma, Italy and 32 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Roma, Italy and 321 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Roma, Lazio, Italy and 312 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Roma, Lazio, Italy and 80 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 141 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 145 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Rome, Italy and 943 other locations
This is an open-label, randomised study in participants with chronic kidney disease (CKD) treated for hyperkalaemia (HK) whilst in ...
Phase 4
Roma, Italy and 47 other locations
The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death ve ...
Phase 3
Roma, Italy and 239 other locations
The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...
Phase 3
Roma, Italy and 405 other locations
Clinical trials
Research sites
Resources
Legal